In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, predicts Roots Analysis

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions.

Roots Analysis is pleased to announce the publication of its recent study, titled, “In Vitro ADME Testing Services Market, 2019-2030”

The  report features an extensive study on the current landscape and the likely future potential of the companies offering in vitro ADME services. The study features an in-depth analysis, highlighting the capabilities of various industry stakeholders. In addition to other elements, the report includes:

§  A detailed assessment of the current market landscape, of companies offering in vitro ADEM testing services. 

§  A schematic logo landscape of in vitro ADME service providers, highlighting their geographical distribution (on the basis of location of headquarters) and company size.

§  A discussion on the various outsourcing business models used in this domain, along with a list of key considerations that need to be taken into account by industry stakeholders while selecting a CRO partner.

§  Elaborate profiles of popular players that offer a wide range of in vitro ADME testing services (shortlisted on the basis of the company size).

§  A detailed peer group-based benchmarking analysis, comparing the involved players based on several relevant parameters related to company and services.

§  A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2005-2018

§  A discussion on the various regulatory guidelines related to in vitro ADME testing, which have been laid down by major international / regional regulatory bodies.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

To request for sample report – https://www.rootsanalysis.com/reports/239/request-sample.html

§  Type of Molecule

§  Small Molecules

§  Biologics

§  Type of Service

§  Absorption Testing

§  Distribution Testing

§  Metabolism and Elimination Testing

§  Type of Assay

§  Caco-2 Permeability Assay

§  PAMPA Permeability Assay

§  MDCK Permeability Assay

§  Protein Binding Assay

§  Blood Brain Barrier Assay

§  Blood to Plasma Ratio

§  Stability / Clearance Assay

§  Enzyme Induction Assay

§  Enzyme Inhibition Assay

§  Metabolite Profiling and Screening / Identification Assay

§  Metabolite Production Assay

§  Reaction Phenotyping Assay

§  Transporter Interactions Assay

§  Target Therapeutic Area

§  Blood Disorders

§  Cardiovascular Disorders

§  Gastrointestinal and Digestive Disorders

§  Hormonal Disorders

§  Infectious Diseases

§  Immunological Disorders

§  Metabolic Disorders

§  Mental Disorders

§  Neurological Disorders

§  Oncological Disorders

§  Respiratory Disorders

§  Skin Disorders

§  Urogenital Disorders

§  Others

To request for customize report - https://www.rootsanalysis.com/reports/239/request-sample.html

§  Type of Sponsor

§  Industry Players

§  Non-Industry Players

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific and Rest of the World

Key companies covered in the report

§  Albany Molecular Research (AMRI)

§  Charles River Laboratories

§  Pharmaceutical Product Development (PPD)

§  RTI International

§  Eurofins Scientific

§  Evotec

§  Galapagos

§  Tecan Group

§  GVK Biosciences

§  Pharmaron

§  <